Article Contents ::
Details About Generic Salt :: Interferon beta–1A
Main Medicine Class:: #N/A Sub Medicine Class :: #N/A
| 14A. IMMUNUOSUPPRESSANTS in 14. IMMUNOLOGY & ALLERGY |
| INTERFERON BETA–1A |
| BIOLOGICAL RESPONSE MODIFIER | ANTIVIRAL, IMMUNOMODULATOR |
| PK: A: 50% (SC), 40% (IM) M: Hepatic E: Renal |
|
Indications & Dose: RELAPSING FORMS OF MULTIPLE SCLEROSIS SC Adult Initially 8.8µg thrice weekly 2wks then titrated to 22µg thrice weekly 2wks, the final dose is increased to 44µg thrice weekly or initially 4.4µg thrice weekly 2wks then titrated to 11µg thrice weekly 2wks, the final dose is increased to 22µg thrice weekly | RELAPSING-REMITTING MULTIPLE SCLEROSIS IM Adult 6MU (30µg) once weekly |
| Contra: refer Interferon alpha-2B
Precautions: refer interferon alpha-2b ADR: Serious: Refer Interferon alpha-2B DDI: Serious Zidovudine level increases, Natalizumab results in multifocal leukoencephalopathy, ACEIs results in severe granulocytopenia Monitor: Refer Interferon alpha-2B |
